AGM/EGM1 Sept 2026, 04:50 pm
Amerise Biosciences Ltd Holds 41st AGM on Sep 24, 2026
AI Summary
Amerise Biosciences Ltd has announced its 41st Annual General Meeting (AGM) to be held on Thursday, September 24, 2026. The meeting will take place at the company's registered office in Ahmedabad. Key agenda items include the adoption of the audited financial statements for the fiscal year 2025-26, along with the reports of the Board of Directors and Auditors. Additionally, the members will vote on the appointment of Mr. Albert Hines as Whole-Time Director and Chief Financial Officer (CFO) for a period of three years, commencing February 2, 2026, with nil remuneration. The filing also includes the Notice of the AGM and the Annual Report for the financial year 2025-26.
Key Highlights
- AGM scheduled for September 24, 2026, to adopt FY26 financial statements.
- Appointment of Albert Hines as Whole-Time Director & CFO proposed.
- Director and CFO appointment is for 3 years with nil remuneration.
- Annual Report for FY2025-26 submitted as per SEBI regulations.
Price Impact
More from AMERISE